SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Hung-Lin Chen, Fei-Yuan Hsiao, Domperidone, cytochrome P450 3A4 isoenzyme inhibitors and ventricular arrhythmia: a nationwide case–crossover study, Pharmacoepidemiology and Drug Safety, 2015, 24, 8
  2. 2
    Chin-Yu Lin, Yenn-Jiang Lin, Li-Wei Lo, Yun-Yu Chen, Eric Chong, Shih-Lin Chang, Fa-Po Chung, Tze-Fan Chao, Yu-Feng Hu, Ta-Chuan Tuan, Jo-Nan Liao, Yaoting Chang, Kuo-Liong Chien, Chuen-Wang Chiou, Shih-Ann Chen, Factors predisposing to ventricular proarrhythmia during antiarrhythmic drug therapy for atrial fibrillation in patients with structurally normal heart, Heart Rhythm, 2015, 12, 7, 1490

    CrossRef

  3. You have free access to this content3
    Leonardo Tamariz, Alexis Rodriguez, Ana Palacio, Hua Li, Robert Myerburg, Racial Disparities in the Use of Catheter Ablation for Atrial Fibrillation and Flutter, Clinical Cardiology, 2014, 37, 12
  4. 4
    Emilie K. Johnson, Caleb P. Nelson, Values and Pitfalls of the Use of Administrative Databases for Outcomes Assessment, The Journal of Urology, 2013, 190, 1, 17

    CrossRef

  5. You have free access to this content5
    Ryan M. Carnahan, Kevin G. Moores, Mini-Sentinel's systematic reviews of validated methods for identifying health outcomes using administrative and claims data: methods and lessons learned, Pharmacoepidemiology and Drug Safety, 2012, 21,
  6. You have free access to this content6
    Ryan M. Carnahan, Mini-Sentinel's systematic reviews of validated methods for identifying health outcomes using administrative data: summary of findings and suggestions for future research, Pharmacoepidemiology and Drug Safety, 2012, 21,
  7. You have free access to this content7
    Richard Platt, Ryan M. Carnahan, Jeffrey S. Brown, Elizabeth Chrischilles, Lesley H. Curtis, Sean Hennessy, Jennifer C. Nelson, Judith A. Racoosin, Melissa Robb, Sebastian Schneeweiss, Sengwee Toh, Mark G. Weiner, The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction, Pharmacoepidemiology and Drug Safety, 2012, 21,